Search Medical Condition
Please enter condition
Please choose location from dropdown

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1154) clinical trials

Do you or a loved one suffer from Parkinson’s disease? Wake Research Associates is enrolling volunteers with Parkinson’s disease in a clinical research study.  

Phase N/A

Memory Loss and Elevated Blood Sugar? A clinical research study is currently evaluating an investigational drug for its safety and effectiveness in slowing further memory loss in patients with mild Alzheimer’s Disease.  

Phase N/A

The Memory Health Center at Summit Research Network, is enrolling participants in the Clarity AD Research Study.  This research study will evaluate whether an investigational study drug is safe and effective in slowing the progression of Alzheimer’s. Study participation may last to up 23 months with the option to participate ...

Phase N/A

A study to evaluate the safety and tolerability of SEP363856 in subjects with Parkinson's Disease Psychosis.  

Phase

A clinical research study is underway, evaluating an investigational study drug for adults with Parkinson's Disease who are experiencing a decline in memory and thinking.

Phase

Study participation will last about a year.   Following a screening period of up to 6 weeks, qualified participants will be randomly assigned to the oral investigational medication, C0R388, or a placebo (an inactive substance).   During the treatment period, the participants will visit the research center 9 times over a 48 ...

Phase

A ten-week study to assess MP-101 in the treatment of psychosis in participants with Alzheimer's Disease, as compared to placebo.

Phase N/A

ActivMed Practices and Research is looking for volunteers to participate in a device research study on Alzheimer's Disease and memory loss.

Phase N/A

The primary objective is to evaluate the effect of neflamapimod on cognitive function as assessed in a study-specific Neuropsychological Test Battery  

Phase